Medicare Grant Proposal
CareGuardAI is applying for a CMS Innovation Center grant to bring medically supervised telehealth respite care to Medicare beneficiaries nationwide — reducing costs, improving outcomes, and giving caregivers the support they deserve.
Significant Cost Savings
Estimated annual Medicare savings from reduced emergency hospitalizations and delayed nursing home placement when caregiver burnout is addressed.
Reduced Hospitalizations
Reduction in avoidable emergency department visits when family caregivers receive adequate respite support, based on peer-reviewed research.
Beneficiaries Served
Projected Medicare beneficiaries served in Year 3 of the grant program, with a focus on rural and underserved communities.
Caregiver Burnout Reduction
Target reduction in caregiver burnout rates among program participants, measured by validated clinical burnout assessment tools.
Program Objectives
The CareGuardAI Medicare Innovation Grant will fund the development, deployment, and clinical validation of a supervised telehealth respite care program for Medicare beneficiaries who serve as primary family caregivers.
Provide supervised telehealth respite care to Medicare beneficiaries who serve as primary family caregivers for Alzheimer's, Dementia, and terminally ill patients.
Reduce avoidable emergency hospitalizations caused by caregiver burnout, patient falls, and inadequate monitoring during caregiver absences.
Delay nursing home placement by enabling patients to remain safely at home longer, supported by technology-assisted respite care.
Establish a replicable, scalable model for AI-assisted caregiver support that can be integrated into the Medicare benefit structure.
Generate clinical evidence supporting the expansion of telehealth respite care as a covered Medicare benefit.
Prioritize access for rural, low-income, and minority Medicare beneficiaries who face the greatest barriers to traditional respite care services.
The Problem We Solve
When family caregivers burn out, patients are hospitalized. When patients are hospitalized unnecessarily, Medicare pays. When patients enter nursing homes prematurely, Medicare pays significantly more. CareGuardAI breaks this cycle.
The average annual cost of nursing home care for a Medicare beneficiary with Alzheimer's exceeds $108,000. Home-based care with adequate caregiver support costs less than $35,000 annually. By preventing premature nursing home placement in just 170,000 patients, this program would save Medicare over $12 billion per year.
Clinical Evidence
Family caregivers who lack adequate respite support are 2.3x more likely to experience a crisis event requiring emergency hospitalization for their care recipient.
— JAMA Internal Medicine, 2022
Personalized music therapy reduces agitation in Alzheimer's patients by 37–42%, with effects lasting up to 4 hours post-session.
— Cochrane Database of Systematic Reviews, 2023
Remote monitoring and telehealth interventions for dementia patients are associated with a 28% reduction in behavioral symptoms and improved caregiver confidence.
— Alzheimer's & Dementia: Translational Research, 2023
Caregiver burnout costs the U.S. healthcare system an estimated $522 billion annually in lost productivity, increased medical utilization, and premature nursing home placement.
— RAND Corporation Health Research, 2021
Access to regular respite care delays nursing home placement by an average of 18 months, representing significant Medicare cost avoidance.
— The Gerontologist, 2022
Grant Implementation Plan
Deploy CareGuardAI to 5,000 Medicare beneficiary caregivers across 3 states, with intensive data collection, clinical outcome measurement, and program refinement.
Scale to 50,000 beneficiaries across 15 states, with particular focus on rural and underserved communities. Publish initial clinical outcomes data.
Full national deployment to 1M+ beneficiaries. Establish CareGuardAI as a standard Medicare-covered benefit with permanent billing infrastructure.